Barometer for Cancer Onko-Sure® has be proven to not only detect cancer but also to filter the progression of the disease through the measurement of FDP in the blood.
Clinical Data & Onko-Sure® There is a host of new and existing clinical data that shows Onko-Sure® is more effective than CEA. In fact with some patient (such as smokers) Onko-Sure® is more that 20% more effective at detecting early stage cancer.
As a general cancer tumor marker Within the scope of international markets, Onko-Sure® is being used and marketed as a general, pan-cancer blood test for the detection of 19 types of cancer.
Onko-Sure® and Lung Cancer Lung cancer is number one for cancer deaths. Onko-Sure® DR70 has been recently researched and published to be a leading marker for lung cancer. Watch the video with CEO, Douglas MacLellan for more details.
